These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28428726)

  • 1. Successful Treatment of Prosthetic Joint Infection due to Vancomycin-resistant Enterococci with Tedizolid.
    Si S; Durkin MJ; Mercier MM; Yarbrough ML; Liang SY
    Infect Dis Clin Pract (Baltim Md); 2017 Mar; 25(2):105-107. PubMed ID: 28428726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.
    Klupp EM; Both A; Belmar Campos C; Büttner H; König C; Christopeit M; Christner M; Aepfelbacher M; Rohde H
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1957-1961. PubMed ID: 27525679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
    Rybak JM; Marx K; Martin CA
    Pharmacotherapy; 2014 Nov; 34(11):1198-208. PubMed ID: 25266820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA.
    Liu X; Tashiro S; Igarashi Y; Takemura W; Kojima N; Morita T; Hayashi M; Enoki Y; Taguchi K; Matsumoto K
    Pharm Res; 2023 Jan; 40(1):187-196. PubMed ID: 36329373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tedizolid: a new oxazolidinone antimicrobial.
    Kisgen JJ; Mansour H; Unger NR; Childs LM
    Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Vancomycin-Resistant Enterococci: Focus on Daptomycin.
    Kohinke RM; Pakyz AL
    Curr Infect Dis Rep; 2017 Oct; 19(10):33. PubMed ID: 28779348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin-resistant enterococci and coagulase-negative staphylococci prevalence among patients attending at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia.
    Ashagrie D; Genet C; Abera B
    PLoS One; 2021; 16(4):e0249823. PubMed ID: 33831089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro efficacy of linezolid against vancomycin resistant Enterococci.
    Hussain MS; Sattar A; Hussain M
    Pak J Pharm Sci; 2018 Sep; 31(5):1853-1857. PubMed ID: 30150180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of vancomycin-resistant enterococci (VRE) at four U.S. wastewater treatment plants that provide effluent for reuse.
    Rosenberg Goldstein RE; Micallef SA; Gibbs SG; George A; Claye E; Sapkota A; Joseph SW; Sapkota AR
    Sci Total Environ; 2014 Jan; 466-467():404-11. PubMed ID: 23933428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of vancomycin-resistant enterococci in the United Arab Emirates: a retrospective analysis of 12 years of national AMR surveillance data.
    Thomsen J; Abdulrazzak NM; AlRand H; ; Menezes GA; Moubareck CA; Everett DB; Senok A; Podbielski A
    Front Public Health; 2023; 11():1275778. PubMed ID: 38089023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis.
    Johnson JA; Feeney ER; Kubiak DW; Corey GR
    Open Forum Infect Dis; 2015 Dec; 2(4):ofv156. PubMed ID: 26677455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal Colonization with Vancomycin-Resistant Enterococci In Hospitalized and Outpatients.
    Trajkovska-Dokic E; Kaftandzieva A; Stojkovska S; Kuzmanovska A; Panovski N
    Open Access Maced J Med Sci; 2015 Mar; 3(1):7-11. PubMed ID: 27275189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of tedizolid as oral treatment for bone and joint infections.
    Miller LG; Flores EA; Launer B; Lee P; Kalkat P; Derrah K; Agrawal S; Schwartz M; Steele G; Kim T; Kuvhenguhwa MS
    Microbiol Spectr; 2023 Sep; 11(5):e0128223. PubMed ID: 37750695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
    Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
    Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options for vancomycin-resistant enterococcal bacteremia.
    Barber KE; King ST; Stover KR; Pogue JM
    Expert Rev Anti Infect Ther; 2015 Mar; 13(3):363-77. PubMed ID: 25661903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.